Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegtibatinase in Classical Homocystinuria (HARMONY)
NCT06247085Phase 3Recruiting
- Sponsor
- Travere Therapeutics
- Start
- Dec 2023
- Primary completion
- Aug 2027
- Modality
- Replacement Enzymes
- Countries
- 14
01
Overview
A Phase 3 trial of pegtibatinase in homocystinuria (HCU), sponsored by Travere Therapeutics. Started Dec 2023; status: recruiting.
02
Drugs
pegtibatinase
03
Conditions
homocystinuria (HCU)
Beyond the preview
Go deeper on NCT06247085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06247085.